Close
  Indian J Med Microbiol
 

Figures 1: OCT before (a) and one month after (b) phacoemulsification with intravitreal bevacizumab in a 44-year-old DCME resolved at one month, with logMar best corrected visual acuity improvement from - 1.3 to - 0.4

Figures 1: OCT before (a) and one month after (b) phacoemulsification with intravitreal bevacizumab in a 44-year-old DCME resolved at one month, with logMar best corrected visual acuity improvement from - 1.3 to - 0.4